Cargando…
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
Hypoxia is one of the most common phenotypes of malignant tumours. Hypoxia leads to the increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes controlling a raft of pro-tumour phenotypes. These include maintenance of the cancer stem cell compartment, epithelia...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966647/ https://www.ncbi.nlm.nih.gov/pubmed/31835751 http://dx.doi.org/10.3390/cancers11121989 |
_version_ | 1783488784358178816 |
---|---|
author | Feng, Jie Byrne, Niall M. Al Jamal, Wafa Coulter, Jonathan A. |
author_facet | Feng, Jie Byrne, Niall M. Al Jamal, Wafa Coulter, Jonathan A. |
author_sort | Feng, Jie |
collection | PubMed |
description | Hypoxia is one of the most common phenotypes of malignant tumours. Hypoxia leads to the increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes controlling a raft of pro-tumour phenotypes. These include maintenance of the cancer stem cell compartment, epithelial-mesenchymal transition (EMT), angiogenesis, immunosuppression, and metabolic reprogramming. Hypoxia can also contribute to the tumour progression in a HIF-independent manner via the activation of a complex signalling network pathway, including JAK-STAT, RhoA/ROCK, NF-κB and PI3/AKT. Recent studies suggest that nanotherapeutics offer a unique opportunity to target the hypoxic microenvironment, enhancing the therapeutic window of conventional therapeutics. In this review, we summarise recent advances in understanding the impact of hypoxia on tumour progression, while outlining possible nanotherapeutic approaches for overcoming hypoxia-mediated resistance. |
format | Online Article Text |
id | pubmed-6966647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69666472020-02-04 Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development Feng, Jie Byrne, Niall M. Al Jamal, Wafa Coulter, Jonathan A. Cancers (Basel) Review Hypoxia is one of the most common phenotypes of malignant tumours. Hypoxia leads to the increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes controlling a raft of pro-tumour phenotypes. These include maintenance of the cancer stem cell compartment, epithelial-mesenchymal transition (EMT), angiogenesis, immunosuppression, and metabolic reprogramming. Hypoxia can also contribute to the tumour progression in a HIF-independent manner via the activation of a complex signalling network pathway, including JAK-STAT, RhoA/ROCK, NF-κB and PI3/AKT. Recent studies suggest that nanotherapeutics offer a unique opportunity to target the hypoxic microenvironment, enhancing the therapeutic window of conventional therapeutics. In this review, we summarise recent advances in understanding the impact of hypoxia on tumour progression, while outlining possible nanotherapeutic approaches for overcoming hypoxia-mediated resistance. MDPI 2019-12-11 /pmc/articles/PMC6966647/ /pubmed/31835751 http://dx.doi.org/10.3390/cancers11121989 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Feng, Jie Byrne, Niall M. Al Jamal, Wafa Coulter, Jonathan A. Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development |
title | Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development |
title_full | Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development |
title_fullStr | Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development |
title_full_unstemmed | Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development |
title_short | Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development |
title_sort | exploiting current understanding of hypoxia mediated tumour progression for nanotherapeutic development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966647/ https://www.ncbi.nlm.nih.gov/pubmed/31835751 http://dx.doi.org/10.3390/cancers11121989 |
work_keys_str_mv | AT fengjie exploitingcurrentunderstandingofhypoxiamediatedtumourprogressionfornanotherapeuticdevelopment AT byrneniallm exploitingcurrentunderstandingofhypoxiamediatedtumourprogressionfornanotherapeuticdevelopment AT aljamalwafa exploitingcurrentunderstandingofhypoxiamediatedtumourprogressionfornanotherapeuticdevelopment AT coulterjonathana exploitingcurrentunderstandingofhypoxiamediatedtumourprogressionfornanotherapeuticdevelopment |